Safety, Tolerability and PK of Imeglimin in Japanese Volunteers
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
This study will assess the pharmacokinetics of single and repeated doses of imeglimin in
healthy Japanese subjects, and the safety and tolerability of single and repeated doses of
imeglimin in healthy Japanese subjects.